1. Home
  2. SEPN vs CRON Comparison

SEPN vs CRON Comparison

Compare SEPN & CRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • CRON
  • Stock Information
  • Founded
  • SEPN 2022
  • CRON 2012
  • Country
  • SEPN United States
  • CRON Canada
  • Employees
  • SEPN N/A
  • CRON N/A
  • Industry
  • SEPN
  • CRON Medicinal Chemicals and Botanical Products
  • Sector
  • SEPN
  • CRON Health Care
  • Exchange
  • SEPN NYSE
  • CRON Nasdaq
  • Market Cap
  • SEPN 631.0M
  • CRON 741.7M
  • IPO Year
  • SEPN 2024
  • CRON N/A
  • Fundamental
  • Price
  • SEPN $5.80
  • CRON $1.97
  • Analyst Decision
  • SEPN Buy
  • CRON Hold
  • Analyst Count
  • SEPN 4
  • CRON 2
  • Target Price
  • SEPN $34.00
  • CRON $3.00
  • AVG Volume (30 Days)
  • SEPN 857.5K
  • CRON 1.7M
  • Earning Date
  • SEPN 02-28-2025
  • CRON 03-03-2025
  • Dividend Yield
  • SEPN N/A
  • CRON N/A
  • EPS Growth
  • SEPN N/A
  • CRON N/A
  • EPS
  • SEPN N/A
  • CRON N/A
  • Revenue
  • SEPN $981,000.00
  • CRON $111,229,000.00
  • Revenue This Year
  • SEPN $406.62
  • CRON $42.83
  • Revenue Next Year
  • SEPN N/A
  • CRON $18.43
  • P/E Ratio
  • SEPN N/A
  • CRON N/A
  • Revenue Growth
  • SEPN N/A
  • CRON 30.31
  • 52 Week Low
  • SEPN $4.17
  • CRON $1.83
  • 52 Week High
  • SEPN $28.99
  • CRON $3.14
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • CRON 51.34
  • Support Level
  • SEPN N/A
  • CRON $1.92
  • Resistance Level
  • SEPN N/A
  • CRON $2.02
  • Average True Range (ATR)
  • SEPN 0.00
  • CRON 0.07
  • MACD
  • SEPN 0.00
  • CRON 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • CRON 48.28

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.

About CRON Cronos Group Inc. Common Share

Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

Share on Social Networks: